Interestingly, evidence suggests that the risk of autoimmunity in CVID is particularly increased in patients bearing a reduction in naïve CD4 cells, RTEs, naïve CD8 and Treg counts (60–62). The gene discussed is CD8A; the disease is common variable immunodeficiency.